IgA Nephropathy Drug With Novel Mechanism Wins FDA Approval
MedPage Today) -- The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary...
Arden Kazmierczak
MedPage Today) -- The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary...
